2018
DOI: 10.1016/j.ijpharm.2018.10.031
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(24 citation statements)
references
References 48 publications
0
24
0
Order By: Relevance
“…[51,52]). Products from rhizomes of C. comosa have been developed for use as an anti-inflammation remedy and for treatment of uterine abnormalities and ovarian hormone deficit [53,54]. [55]; b, Puangpairote [56]; c, Jenjittikul and Larsen [57]; d, Larsen [6]; e, Maknoi et al [49]; f, Boonma and Saensouk [48]; g, Chen et al [58]; and h, Puangpairote et al [59].…”
Section: The Genus Curcuma In Thailandmentioning
confidence: 99%
“…[51,52]). Products from rhizomes of C. comosa have been developed for use as an anti-inflammation remedy and for treatment of uterine abnormalities and ovarian hormone deficit [53,54]. [55]; b, Puangpairote [56]; c, Jenjittikul and Larsen [57]; d, Larsen [6]; e, Maknoi et al [49]; f, Boonma and Saensouk [48]; g, Chen et al [58]; and h, Puangpairote et al [59].…”
Section: The Genus Curcuma In Thailandmentioning
confidence: 99%
“…This study introduced the potential of liquisolid tablets for formulation of viscous and oleoresins like natural crude extracts. 48 Pathak et al 2019 presented a path breaking study upon potential usage of many natural origin gums as matrices and carriers for liquisolid technology by modifying them as needed. This study indicated usage of modified polysaccharides as potential carriers which was achieved by modifying the natural gums viz.…”
Section: Usage Of Natural Polymers and In Herbal Formulationsmentioning
confidence: 99%
“…Based on preliminary trials, the drug-loaded powders (GBD-MCC and GBD-LAC) were blended with the disintegrant (polyplasdone XL10), colloidal silicon dioxide, and magnesium stearate (see Table 1). [32][33][34] The powder mixtures were then compressed using a single-punch machine (Erweka) equipped with 8 mm biconvex punch to produce tablets of average weight 200±5 mg. Tablet hardness was adjusted to achieve a tablet friability of .1% and a disintegration time of .1 minute, thus resembling the reference commercial product (GBD-COM) Semi Daonil™. Formulations of unprocessed micronized GBD particles (GBD-MCC-MIC and GBD-LAC-MIC) were prepared similarly using raw micronized GBD suspensions instead of GBD nanosuspensions.…”
Section: Preparation Of Tablet Formulationsmentioning
confidence: 99%